neurology
TIA Assessment (ABCD2)
TIA risk stratification with ABCD2 score and urgent secondary prevention
Source: NICE NG128 / NICE CG68
Step 1 of ~8
info
TIA Assessment
TIA = transient neurological deficit resolving within 24h (usually <1h). Stroke risk highest in first 48h. Do not send home without risk stratification.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Dipyridamole (Secondary Stroke Prevention) · Antiplatelet — Phosphodiesterase Inhibitor / Adenosine Uptake Inhibitor
- Clopidogrel (Stroke/TIA Secondary Prevention) · Antiplatelet (P2Y12 Inhibitor)
- Vorapaxar · PAR-1 (Protease-Activated Receptor-1) Antagonist — Secondary Prevention in PAD / MI
- Neostigmine · Anticholinesterase (Reversal Agent)
- Prilocaine · Local Anaesthetic (Amide)
- Mepivacaine with adrenaline · Amide LA + vasoconstrictor
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only. Always apply local guidelines and clinical judgement.